Logo

American Heart Association

  1
  0


Final ID: TMP99

Characterization of Large Vessel Occlusion Stroke in Head and Neck Cancer Survivors treated with Endovascular Therapy

Abstract Body: Background: Head and neck cancer (HNC) survivors have more than double the risk of ischemic stroke relative to the general population, attributed to radiation-induced carotid vasculopathy. Yet the characteristics of large vessel occlusion (LVO) stroke in HNC survivors is undefined. This study aimed to characterize LVO strokes among HNC survivors who received endovascular therapy (EVT).
Methods: Retrospective analysis of a single-center prospective stroke registry of EVT patients from January 2021 to January 2024. Patients were divided into three groups: HNC, other cancer (other-CA) and no cancer (non-CA). Demographic data, clinical characteristics, and procedural variables were compared between groups. Primary outcomes were functional independence (modified Rankin Scale [mRS] 0-2) and mortality at 90 days. Multivariable binary and multinominal logistic analyses were performed to adjust for baseline imbalances.
Results: Among 1004 patients undergoing EVT in this cohort, 884 (88.0%) were non-CA, 110 (11.0%) had other-CA, and 10 (1.0%) had HNC status post neck radiation therapy. The median [IQR] age of HNC patients were significantly younger (63.5 years [IQR: 61.3–69]), compared to both non-CA and other-CA groups (72 years [IQR: 61–80] and 73.5 years [IQR: 65–82], respectively), p = 0.02. The prevalence of tandem carotid occlusion requiring angioplasty or stenting was 90% in the HNC group, whereas it was 15.3% in non-CA and 10.8% in other-CA groups (adjusted odd ratio (aOR) 48.7, 95% CI [8.1 – 830], p=<0.001). HNC patients were less likely to achieve complete reperfusion compared to the other 2 groups (40.0 % vs 48.5 % vs 61.8 %; aOR 1.6, 95% CI [1.09 – 2.4], p=0.01). The rate of mRS 0-2 at 90 days was 55.5% in the HNC group, compared to the 33.4% in non-CA or 32.2% in other-CA, which did not reach statistical significance (p = 0.4). There was no statistically significant difference in the age-adjusted mortality rate at 90 days among the 3 groups.
Conclusion:
HNC survivors with LVO stroke referred for EVT were younger but had extremely high prevalence of tandem carotid occlusion requiring angioplasty and stenting. They experienced comparable rates of functional outcomes and mortality, despite lower rates of complete reperfusion relative to non-HNC groups. The findings support the need for early monitoring and prevention for accelerated carotid vasculopathy in this population.
  • Al-qudah, Abdullah  ( UPMC Stroke Institute , Pittsburgh , Pennsylvania , United States )
  • Johnson, Jonas  ( Eye & Ear Institute of Pittsburgh , Pittsburgh , Pennsylvania , United States )
  • Al-bayati, Alhamza  ( UPMC Stroke Institute , Pittsburgh , Pennsylvania , United States )
  • Nogueira, Raul  ( UPMC Stroke Institute , Pittsburgh , Pennsylvania , United States )
  • Rocha, Marcelo  ( UPMC Stroke Institute , Pittsburgh , Pennsylvania , United States )
  • Doheim, Mohamed  ( UPMC Stroke Institute , Pittsburgh , Pennsylvania , United States )
  • Bhatt, Nirav  ( UPMC Stroke Institute , Pittsburgh , Pennsylvania , United States )
  • Rios Rocha, Lucas  ( UPMC Stroke Institute , Pittsburgh , Pennsylvania , United States )
  • Xkhalifax, Xmoustafax  ( University of Pittsburgh , Pittsburgh , Pennsylvania , United States )
  • Starr, Matthew  ( UPMC Stroke Institute , Pittsburgh , Pennsylvania , United States )
  • Nilsen, Marci  ( Eye & Ear Institute of Pittsburgh , Pittsburgh , Pennsylvania , United States )
  • Lang, Michael  ( UPMC Department of Neurosurgery , Pittsburgh , Pennsylvania , United States )
  • Gross, Bradley  ( UPMC Department of Neurosurgery , Pittsburgh , Pennsylvania , United States )
  • Author Disclosures:
    Abdullah Al-Qudah: DO NOT have relevant financial relationships | Jonas Johnson: DO NOT have relevant financial relationships | Alhamza Al-Bayati: DO NOT have relevant financial relationships | Raul Nogueira: DO have relevant financial relationships ; Consultant:Stryker:Active (exists now) ; Consultant:Phenox:Active (exists now) ; Individual Stocks/Stock Options:Vesalio:Active (exists now) ; Individual Stocks/Stock Options:Rapid Pulse:Active (exists now) ; Individual Stocks/Stock Options:Euphrates :Active (exists now) ; Individual Stocks/Stock Options:Brainomix:Active (exists now) ; Individual Stocks/Stock Options:Viz.AI:Active (exists now) ; Consultant:Perfuze:Active (exists now) ; Consultant:Route 92:Active (exists now) ; Consultant:Imperative Care:Active (exists now) ; Consultant:Microvention:Active (exists now) ; Consultant:Medtronic :Active (exists now) ; Consultant:Cerenovus:Active (exists now) | Marcelo Rocha: DO NOT have relevant financial relationships | Mohamed Doheim: DO NOT have relevant financial relationships | Nirav Bhatt: DO NOT have relevant financial relationships | Lucas Rios Rocha: DO NOT have relevant financial relationships | xMoustafax xKhalifax: DO NOT have relevant financial relationships | Matthew Starr: DO NOT have relevant financial relationships | Marci Nilsen: No Answer | Michael Lang: No Answer | Bradley Gross: DO have relevant financial relationships ; Consultant:Medtronic:Active (exists now) ; Consultant:Stryker:Active (exists now) ; Consultant:Microvention:Active (exists now)
Meeting Info:
Session Info:

Risk Factors and Prevention Moderated Poster Tour II

Thursday, 02/06/2025 , 06:00PM - 07:00PM

Moderated Poster Abstract Session

More abstracts on this topic:
A Pharmacovigilance Study of Bempedoic Acid: Balancing Risks and Benefits

Khadka Sulochana, Timilsina Bibek, Matai Pallavi, Sharma Seema, Rajak Kripa, Calderon Barahona Gabriela, Oli Seema

Carotid Revascularization and Medical Management for Asymptomatic Carotid Stenosis: CREST-2 Update

Meschia James, Chaturvedi Seemant, Chimowitz Marc, Demaerschalk Bart, Howard Virginia, Huston John, Lazar Ronald, Moore Wesley, Benson Richard, Voeks Jenifer, Brott Thomas, Howard George, Lal Brajesh, Jones Michael, Heck Donald, Turan Tanya, Roubin Gary, Brown Robert, Barrett Kevin

More abstracts from these authors:
Beyond Recanalization: Predicting Poor Outcomes in Successful Vertebrobasilar Thrombectomy

Doheim Mohamed, Rocha Marcelo, Starr Matthew, Bhatt Nirav, Lang Michael, Gross Bradley, Raul Nogueira, Al-bayati Alhamza, Rios Rocha Lucas, Katano Takehiro, Al-qudah Abdullah, Xkhalifax Xmoustafax, Almast Anmol, Miao Christopher, Pillai Bharat, Palegar Thanmayi

Impact of Age and Posterior Circulation Collateral Status on Outcomes in Vertebrobasilar Artery Occlusion Patients Undergoing Endovascular Thrombectomy

Doheim Mohamed, Raul Nogueira, Rocha Marcelo, Al-qudah Abdullah, Katano Takehiro, Rios Rocha Lucas, Bhatt Nirav, Starr Matthew, Lang Michael, Gross Bradley, Al-bayati Alhamza

You have to be authorized to contact abstract author. Please, Login
Not Available

Readers' Comments

We encourage you to enter the discussion by posting your comments and questions below.

Presenters will be notified of your post so that they can respond as appropriate.

This discussion platform is provided to foster engagement, and simulate conversation and knowledge sharing.

 

You have to be authorized to post a comment. Please, Login or Signup.


   Rate this abstract  (Maximum characters: 500)